EXPERIENCES WITH CHRONIC IDIOPATIC COUGH PATIENTS TREATED WITH LOW-DOSE ITRACONAZOLE

EXPERIENCES WITH CHRONIC IDIOPATIC COUGH PATIENTS TREATED WITH LOW-DOSE ITRACONAZOLE - EXPERIENCES WITH CHRONIC IDIOPATIC COUGH PATIENTS TREATED WITH LOW-DOSE ITRACONAZOLE

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000004933

Enrollment

Registered

2011-01-29

Start date

2011-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic idiopathic cough

Interventions

oral prednisolone (10 mg/day) a low dose of ITZ (50 mg/day)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: CIC patients who are suffering from cough symptoms more than 2years.

Exclusion criteria

Exclusion criteria: 1) Patients having abnormal shadow on chest X-ray 2) Patients having wheezing audible 3) Patients having obstructive disorders in pulmonary function testing 4) Patients having severe complications 5) Patients having pulmonary tuberclosis 6) Jpatients without agreement 7) Patients being pregnant, possible pregnant or breast-feeding a baby 8) Patients judged inappropriate by attending physisians

Design outcomes

Primary

Measure	Time frame
The clinical response to each treatment was monitored by changes in cough sensitivity and the Leicester Cough Questionnaire (LCQ) measured during the 2-week periods at the end of each phase.	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026